Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam oral solution vs chloral hydrate for neonatal MRI sedation
ChiCTR2300069996Phase 4Not yet recruiting
- Sponsor
- Chengdu Women's and Children's Central Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of midazolam (2 arms), sponsored by Chengdu Women's and Children's Central Hospital. Primary endpoint: successful sedation. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
midazolam
Beyond the preview
Go deeper on ChiCTR2300069996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069996.